TGF-beta induced RBL2 expression in renal cancer cells by down-regulating miR-93

[1] Roberts AB(1998)Molecular and cell biology of TGF-beta Miner Electrolyte Metab 24 111-119

[2] Brizzi MF(2004)RAGE- and TGF-beta receptor-mediated signals converge on STAT5 and p21waf to control cell-cycle progression of mesangial cells: a possible role in the development and progression of diabetic nephropathy FASEB J. 18 1249-1251

[3] Dentelli P(2001)High glucose-induced hypertrophy of mesangial cells requires p27(Kip1), an inhibitor of cyclin-dependent kinases Am J Pathol 158 1091-1100

[4] Rosso A(2006)Role of transforming growth factor beta in cancer progression Future Oncol 2 743-763

[5] Calvi C(2013)Attenuation of Smad2 activity shows resistance to TGF-β signalling in mammary adenocarcinoma (MCF-7) cells Cell Biol Int 37 449-457

[6] Gambino R(2012)Complexities of TGF-β targeted cancer therapy Int J Biol Sci. 8 964-978

[7] Cassader M(2012)TGF-β signalling and its role in cancer progression and metastasis Cancer Metastasis Rev 31 553-568

[8] Wolf G(1996)DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 271 350-353

[9] Schroeder R(1997)Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma Lab Invest 76 739-749

[10] Zahner G(2012)TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von Hippel–Lindau tumor suppressor Urology 79 966.e1-966.e7

[1] Roberts AB(1998)Molecular and cell biology of TGF-beta Miner Electrolyte Metab 24 111-119

[2] Brizzi MF(2004)RAGE- and TGF-beta receptor-mediated signals converge on STAT5 and p21waf to control cell-cycle progression of mesangial cells: a possible role in the development and progression of diabetic nephropathy FASEB J. 18 1249-1251

[3] Dentelli P(2001)High glucose-induced hypertrophy of mesangial cells requires p27(Kip1), an inhibitor of cyclin-dependent kinases Am J Pathol 158 1091-1100

[4] Rosso A(2006)Role of transforming growth factor beta in cancer progression Future Oncol 2 743-763

[5] Calvi C(2013)Attenuation of Smad2 activity shows resistance to TGF-β signalling in mammary adenocarcinoma (MCF-7) cells Cell Biol Int 37 449-457

[6] Gambino R(2012)Complexities of TGF-β targeted cancer therapy Int J Biol Sci. 8 964-978

[7] Cassader M(2012)TGF-β signalling and its role in cancer progression and metastasis Cancer Metastasis Rev 31 553-568

[8] Wolf G(1996)DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 271 350-353

[9] Schroeder R(1997)Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma Lab Invest 76 739-749

[10] Zahner G(2012)TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von Hippel–Lindau tumor suppressor Urology 79 966.e1-966.e7